Pharmaceutical Technology

JANUARY 21, 2025

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

Side effects 138

Side effects 138

MedCity News

JANUARY 30, 2025

Phase 2 data for Cargo Therapeutics CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events. Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. The post Safety Risk Sinks Cargo Therapeutics Cancer Cell Therapy Prospect, Leading to 50% Staff Cut appeared first on MedCity News.

Prospecting 291

Prospecting Safety Leads Biopharma 291

PharmaVoice

JANUARY 6, 2025

How regulators could hit PBMs from multiple sides in the coming year.

325

325

European Pharmaceutical Review

JANUARY 3, 2025

Researchers have developed a high performance liquid chromatography (HPLC) method that enables accurate determination and precise impurity analysis of the adrenergic -receptor blocker Carvedilol. Carvedilol is commonly used drug to treat cardiovascular diseases , Yuan et al. explained. While there are a variety of methods that can detect and quantify carvedilol, these methods often have limitations in terms of sensitivity, selectivity, or the ability to simultaneously quantify carvedilol and its

Pharmaceutical manufacturing 109

Pharmaceutical manufacturing Manufacturing Pharmaceutical Safety 109

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

pharmaphorum

JANUARY 13, 2025

Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae.The $7.22-per-share deal for 89.8% of Sage is a 30% premium on the company's share price on Friday and is estimated by Reuters to be worth around $442 million. Biogen has a longstanding alliance in place with Sage and co-markets Zurzuvae (zuranolone), which is FDA-approved for post-partum depression (PPD).

FDA 105

FDA Marketing 105

PM360

JANUARY 24, 2025

AI drives automation and optimization that empower pharmaceutical marketers to rapidly scale commercialization-oriented content and activities. Transformation is a word often paired with artificial intelligence (AI). The transformative impact of AI on pharmaceutical marketing is significant, with much to consider regarding its promise and how its reshaping the industry.

Marketing 64

Marketing Pharmaceutical Sales pitches Pharma 64

MedCity News

JANUARY 15, 2025

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer, HIV and other conditions. The post Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings appeared first on MedCity News.

Healthcare 325

Healthcare Healthcare Prescription Medical 325

PharmaVoice

JANUARY 2, 2025

A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.

321

321

European Pharmaceutical Review

JANUARY 7, 2025

The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.

Food and Drug Administration 105

Food and Drug Administration FDA Food Medical 105

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

Pharma Marketing Network

JANUARY 11, 2025

Table of Contents Sr# Headings 1 Introduction: The Power of SEO Campaigns in Pharma Marketing 2 Crafting an Effective SEO Strategy for Pharma Marketing 3 Leveraging Content Marketing in SEO Campaigns 4 Measuring Success and Optimizing SEO Campaigns Introduction: The Power of SEO Campaigns in Pharma Marketing In todays competitive digital landscape, SEO campaigns have become an indispensable tool for pharma marketing executives.

Marketing 52

Marketing Pharma Engineering Healthcare Provider 52

Eversana Intouch

JANUARY 28, 2025

In a rapidly evolving industry, staying ahead of the curve is critical. In PM360 ‘s article, What Is Pharma Marketing in 2025 ? Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. Applied AI Although AI promises a great return on investment, the pharma industry has been slow to adopt it due to ethical, regulatory, and compliance hurdles.

Marketing 59

Marketing Pharma Ethics Education 59

Close-Up CRM

JANUARY 9, 2025

Pharma marketing is no longer about mass messaging or relying solely on blockbuster drugs to win the market. The landscape has evolved, driven by informed stakeholders, tighter compliance regulations, and the demand for more personalized interactions. Closed-Loop Marketing (CLM) emerges as a transformative approachnot just a strategy but a necessity in todays pharmaceutical environment.

Marketing 52

Marketing Pharma CRM Sales 52

MedCity News

JANUARY 31, 2025

We are living in a moment when many realize that collaboration yields better, faster and more affordable advances. Open source also enables the potential for bigger profits and revenue. Whats in reach: a small amount of money paid for treatments across millions of people, rather than expensive lifesaving treatments only for the few who can afford them.

Healthcare 321

Healthcare Healthcare Medical Physicians 321

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmaVoice

JANUARY 14, 2025

Merck looks ahead with an array of cardiometabolic, immunology, neuroscience and ophthalmology pipelines.

290

290

European Pharmaceutical Review

JANUARY 14, 2025

New long-term data reveals that a modifier gene therapy delivered meaningful visual function improvements for retinitis pigmentosa participants in a Phase I/II clinical trial. A two-year safety and efficacy update from the OCU400 clinical trial showed that 100 percent of treated evaluable participants improved or preserved their visual function compared to untreated eyes at both one and two years.

Safety 86

Safety Medicine Patients Medical 86

Pharma Marketing Network

JANUARY 11, 2025

Table of Contents Sr# Headings 1 Introduction: The Power of Pharmaceutical Advertising 2 Crafting Effective Pharmaceutical Advertising Campaigns 3 Navigating Regulations in Pharma Advertising 4 Leveraging Technology and Trends in Pharma Marketing Introduction: The Power of Pharmaceutical Advertising Pharmaceutical advertising plays a pivotal role in shaping healthcare decisions, bridging the gap between pharma companies, healthcare providers, and patients.

Pharmaceutical 52

Pharmaceutical Marketing Pharma Healthcare Provider 52

Silver Line CRM

JANUARY 30, 2025

Reading time: 3 minutes The pharmaceutical and medtech industries are tackling some of the toughest challenges in healthcare, from improving patient care to navigating complex regulations. Salesforce Life Sciences Cloud is stepping in as a powerful tool to help these industries work smarter, not harder. By combining AI, real-time data, and advanced tools, Life Sciences Cloud creates new opportunities to modernize processes, and Mphasis Silverline is at the forefront of partners innovating on the

Pharma 52

Pharma Customer Relationship Management Healthcare Healthcare 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PM360

JANUARY 24, 2025

Sometimes the human element can make all the difference. For instance, take the story of Captain Chesley Sully Sullenberger, who was piloting the U.S. Airways Flight 1549 in January 2009, when it hit a flock of geese, disabling both its engines. 1 The flights systems suggested he should land at LaGuardia or divert to another nearby airport. But Sullys years of experience and judgment told him those options were too risky.

Sales 52

Sales Pharma sales reps Prescription Patients 52

MedCity News

JANUARY 8, 2025

Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagships Valo Health appeared first on MedCity News.

Biopharma 317

Biopharma Pharma 317

PharmaVoice

JANUARY 27, 2025

Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.

279

279

European Pharmaceutical Review

JANUARY 17, 2025

A new collaborative report provides best practice recommendations on using surrogate endpoints in health economic models to guide decisions about health technology assessment (HTA). The National Institute of Health and Care Excellence (NICE) explained that HTA bodies assess evidence on the short-term effects of a drug provided by companies and drug developers.

Pharmaceutical 64

Pharmaceutical Medicine Marketing 64

Advertisement

PharmaTimes

JANUARY 22, 2025

Europes first biomarker trial seeks to prevent Crohns Disease onset

138

138

The Marketing Advantage

JANUARY 15, 2025

Given the limitations of some of the most common methods of evaluating a sales compensation plans effectiveness, how can life sciences companies achieve the robust examination necessary to ensure their plans are maximizing sales force motivation and, accordingly, maximizing sales? This blog presents a statistically based diagnostic system developed by The Marketing Advantage, Inc. to evaluate sales compensation plan effectiveness: SCORES.

Sales 52

Sales Consulting Safety Leads 52

PM360

JANUARY 24, 2025

Whats in store for 2025? For the past nine years, EVERSANA INTOUCH has done a look ahead: a forecast based on input from leaders on what trends may shape pharma marketing in the year ahead. Unlike previous years where five to seven trends were examined, the 2025 report narrowed its focus to three that matter most and will make the most impact across the pharma landscape this year: applied AI, the Direct-to-Patient (DTP) model, as well as globalization and health equity.

Marketing 52

Marketing Pharma Healthcare Healthcare 52

MedCity News

JANUARY 2, 2025

Many healthcare AI developers lack access to real-world data. To address this, Atropos Health is allowing AI developers to train and deploy their models using its real-world evidence network. The federated healthcare data network consists of more than 300 million patient records gathered from EHRs, claims data and patient registries. The post AI Developers Need Real-World Data and Atropos Health Is Stepping Up to Help appeared first on MedCity News.

Networking 312

Networking Training Healthcare Healthcare 312

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaVoice

JANUARY 9, 2025

Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.

279

279

European Pharmaceutical Review

JANUARY 31, 2025

The National Institute for Health and Care Excellence (NICE) has issued positive final draft guidance for a one-off gene therapy which provides a potential cure for certain patients with severe sickle cell disease. This approval of CASGEVY (exagamglogene autotemcel) is indicated for individuals 12 years and older who have certain types of severe sickle cell disease.

Management 59

Management Patients Pharmaceutical Medicine 59

Healthcare Success

JANUARY 6, 2025

Are the digital tracking technologies you use for your website and healthcare marketing practices fully compliant with HIPAA regulations and digital tracking standards? You might think so, but even industry standards like the Google Analytics (G4) and Meta pixels are not compliant. To understand these issues better, I invite you to listen to my recent podcast guest, James Corr from Freshpaint, as he sheds light on critical issues most healthcare providers overlook.

Healthcare 59

Healthcare Healthcare Marketing Insurance 59